CSI Market
Sign In | Register

Cryo cell International Inc (CCEL) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access CCEL quarterly Cash Flow →
The data below summarizes Cryo cell International Inc's cash flow activity from Nov 30 2021 to Nov 30 2025, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Nov 30 2025)
12 Months 		(Nov 30 2024) (Nov 30 2023) (Nov 30 2022) (Nov 30 2021)
Operating Activities
Income-2.43
Depreciation & amortization0.99
Amortization of Other Assets0.02
Increase (Decrease) in Deferred Revenue0.00
Other Asset Impairment Charges4.36
Provision For Loan Losses Expensed0.87
Increase (Decrease) in Inventories0.06
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.05
Share-based Compensation0.42
Income (Loss) from Equity Method Investments0.00
Gain (Loss) on Contract Termination0.00
Depreciation And Amortization Expense-
Abandonment Of Patents-
Equity In Income Loss Of Affiliates-
Write Off Of Note Receivable-
Increase Decrease In Deposits And Other Assets-0.10
Goodwill And Intangible Asset Impairment-
Marketable Securities Unrealized Gain Loss0.81
Increase Decrease In Operating Lease Liability-0.42
Operating Lease Right Of Use Asset Amortization Expense0.38
Increase Decrease In Contract With Customer Liability4.36
Income taxes-2.82
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.41
Increase (Decrease) in Accounts Payable1.00
Increase (Decrease) in Accrued Liabilities-1.53
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.06
Other Working Capital-0.18
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities5.48
Investing Activities
Capital Expenditures-0.23
Sale of Capital Items0.12
Proceeds from Sale and Maturity of Marketable Securities2.79
Short-term Investments Acq.0.00
Real Estate Investments0.00
Purchases Of Marketable Securities And Other Investments-
Payment Of Duke License Agreement-
Payments To Acquire Marketable Securities And Other Investments-3.65
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross0.00
Payments to Fund Long-term Loans to Related Parties0.00
Sale of businesses0.00
Accounts payable0.00
Payments to Acquire Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.98
Financing Activities
Short-term debt Net-1.22
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.15
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-0.15
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Increase Decrease In Long Term Liability Revenue Sharing Agreements-
Extinguishment Of Revenue Sharing Agreements-
Litigation Settlement Amount Awarded To Other Party-
Payment Of Earnout-
Payments For Extinguishment Of Revenue Sharing Agreements-
Issuance Costs Associated With The Proceeds From The Note Payable-
Proceeds From Swap Termination-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-3.23
Net Cash Flow from Financing Activities-4.75
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow5.36
Total Cash Flow-0.24
4 historic quarters locked

Sign in to unlock the full Cryo cell International Inc cash flow history.

Sign In Create Free Account

About Cryo Cell International Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251130)
  • Filed with the SEC: February 27, 2026
  • Source: ccel-20251130.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-083096

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License